Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: $8M quarter? - Based on share buyback$

$8M quarter? - Based on share buyback$

posted on Jun 16, 2008 02:49PM

If they've purchased 2.8M shares since April, and considering they're buyback plan has a minimum purchase of 10% of the revenue generated by MMP licensing, it could mean a $10M quarter or so. 2.8M at an average pps of about 32 cents since then give us 2.8M x$0.32 = $896K, and $896K is 10% of $9M, so I'm guessing at these prices they've bought MORE than then minimum allowable, so I'll say the quarter will come in somwhere between $5M & $8M in PTSC's half of the PDS revenues. Not a bad quarter all things considered if I'm in the ballpark.

Share
New Message
Please login to post a reply